• Home
  • HCN Trends
  • Contact Us

Search Articles

Cardiology Covid-19 Dermatology Endocrinology General Interest Hematology Infectious Disease Neurology Oncology Pediatrics Psychiatry Pulmonology Rheumatology Surgery Uncategorized
acetaminophen actemra adverse events anemia antibody anxiety azithromycin bipolar disorder bleeding blog brain tumor breast cancer burnout Cancer capecitabine capmatinib cervical cancer chloroquine chronic pain clinical trials cloroquine CME compensation coronary artery disease coronavirus cost covid-19 death diagnosis doctors dosing drug interactions efficacy erlotinib exercise FDA/regulation fever filters glioblastoma green tea guidelines hemophilia hiv hospital hydroxychloroquine ibrutinib ibuprofen immunity induction chemotherapy infectious disease influenza ipilimumab irinotecan iron-deficiency anemia isn letrozole leukemia Lung cancer malaria mask Masks mbc MDS medical cannabis medical school Medicine mesothelioma metastatic colorectal cancer Myelodysplastic Syndromes myeloid leukemia nivolumab nsclc olaparib osimertinib outcomes pandemic patient safety patients pediatrics perjeta physicians podcast practice practice management prevention procedure prostate cancer radiation remdesivir research/studies respirators respiratory retevmo rucaparib sars SCLC selinexor selpercatinib sorafenib stroke Survival/Mortality symptoms syndrome telemedicine testing therapy thrombosis thyroid cancer time tnbc tocilizumab trastuzumab treatment vaccine venetoclax xpovio

January 05, 2021 | Oncology
Oncology’s Future; CLL Treatments; 6 Things Making You Fat

M3 These Physician Specialties Have the Brightest Futures

2020 was brutal for healthcare workers, no question. Based on more than 1,250 responses from a survey sent out about how the pandemic has affected them both personally and professionally, MDLinx learned that roughly half of healthcare workers are seriously rethinking their careers or practice. Half! So then what is the outlook for 2021? Does […]

Millennium Medical Publishing Choosing Between Novel Agents and Chemoimmunotherapy in CLL

From the pages of Clinical Advances in Hematology & Oncology comes this Q&A with Jennifer A. Woyach, MD, a Professor of Medicine in the Division of Hematology at the Ohio State University Comprehensive Cancer Center. Dr. Woyach provides extensive commentary on BTK, BCL2, and PI3K inhibitors, FCR usage, and the importance of clinical trials when […]

M3 6 Seemingly Harmless Habits That Pack on the Pounds

Now that 2021 is here, you’re not alone in trying to possibly lose weight. In fact, an estimated 45 million Americans go on some sort of diet each year. But are you sabotaging yourself even before you get started? As you think about your health goals in this new year, be sure you’re not falling […]
  • © Healthcare Communications Network
  • Privacy Policy